We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Scott Fosko

Scott W Fosko MD

Professor and Chair, Director, Mohs Surgery and Cutaneous Oncology, Saint Louis University Department of Dermatology Interim Director, Saint Louis University Cancer Center, St. Louis, MO

Dr. Scott W. Fosko is Professor and Chair, Department of Dermatology Saint Louis University School of Medicine and serves as the Interim Director, Saint Louis University Cancer Center. He is Past-President of the American College of Mohs Surgery.  Dr. Fosko has been a member of the Faculty of Saint Louis University since 1993, when he developed the first Mohs Surgery Division, and serves as the Director of Mohs Surgery and Cutaneous Oncology.  Dr. Fosko is an active clinical researcher with a particular focus on high risk basal cell and squamous cell carcinomas, and lentiginous melanoma.  His focus on providing outstanding patient care is based on a foundation of early and effective multidisciplinary care for the high risk patients. He has served as the principal investigator on multiple studies and currently is studying basal cell carcinoma response to vismodegib based on histologic subtype, an investigator initiated study.

Dr. Fosko is the former Residency Program Director and expanded the residency program from 6 to 12 ACGME approved positions. He formerly was the Fellowship Director for the American College of Mohs Surgery accredited Mohs Surgery and Cutaneous Oncology, Laser and Cosmetic Fellowship and has trained 8 fellows to date. He is an active Faculty member in the Clinical Research Unit and is engaged in the education of the Clinical Research Fellows. As Chair, he supported the development of the current ACGME approved Dermatopathology Fellowship.

Recent Contributions to PracticeUpdate:

  1. Vismodegib Safe and Effective in Advanced Basal Cell Carcinoma